Ledger.Open graph →

SEC Form D · filed December 12, 2019

VistaGen Therapeutics, Inc

Offering

$650K

Sold

$650K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

South San Francisco, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Jerrold D. Dotson · South San Francisco, CAExec H. R. Snodgrass · South San Francisco, CAExec · Director Jerry B. Gin · South San Francisco, CADirector Ann K. Cunningham · South San Francisco, CADirector Mark A. Mcpartland · South San Francisco, CAExec Shawn K. Singh · South San Francisco, CAExec · Director Jon S. Saxe · South San Francisco, CADirector Brian J. Underdown · South San Francisco, CADirector Mark A. Smith · South San Francisco, CAExec Tyler Tringas · Miami, FLDirector Yanghee Paik · Buena Park, CAExec R. D. Ravnaas · Forth Worth, TXDirector Earl Webb · Chicago, ILExec Joon H. Hwang · Seoul, M5Director Asia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · Director Barrett R. Sigmund · Seattle, WAExec Mark W. Brooker · Houston, TXDirector Mark Rose · Chicago, ILExec · Director Ishaan Nerurkar · Berkeley, CADirector Michael Theilmann · Berkeley, CAExec · Director Colton Jang · Berkeley, CAExec Paul G. Roess · Chattanooga, TNExec · Director Mark W. Piper · SEATTLE, WAExec Scott Gazelle · Richmond, VADirector Steve Wallace · Richmond, VAExec Donna Edmonds · Richmond, VADirector Thomas P. Hoban, Jr · EVERETT, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗